Bio-Rad Laboratories (NYSE:BIO) Downgraded to “Hold” Rating by Wall Street Zen
Wall Street Zen lowered shares of Bio-Rad Laboratories (NYSE:BIO – Free Report) from a buy rating to a hold rating in a research report report published on Sunday morning. Other equities research analysts also recently issued reports about the company. Royal Bank of Canada dropped their target price on Bio-Rad Laboratories from $409.00 to $392.00 […]
Wall Street Zen lowered shares of Bio-Rad Laboratories (NYSE:BIO – Free Report) from a buy rating to a hold rating in a research report report published on Sunday morning. Other equities research analysts also recently issued reports about the company. Royal Bank of Canada dropped their target price on Bio-Rad Laboratories from $409.00 to $392.00 […]
